WallStreetZenWallStreetZen

NASDAQ: GTBP
Gt Biopharma Inc Stock Ownership - Who owns Gt Biopharma?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Gt Biopharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Michael Martin BreenExecutive ChairmanInterim CEO2023-08-11200,000$0.29
$57.40kBuy
Manu OhriCFO Secretary2023-08-11200,000$0.29
$57.40kBuy
Manu OhriCFO Secretary2023-08-11200,000$0.29
$57.40kSell
Manu OhriCFO Secretary2023-08-11200,000$0.29
$57.40kBuy

1 of 1

GTBP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GTBP insiders and whales buy or sell their stock.

GTBP Shareholders

What type of owners hold Gt Biopharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Dekabank Deutsche Girozentrale77.20%1,093,645$4.10MInstitution
Michael Martin Breen60.44%856,218$3.21MInsider
Manu Ohri24.71%350,000$1.31MInsider
Vanguard Group Inc1.45%20,512$76.92kInstitution
Bank Of Montreal1.40%19,872$74.52kInstitution
Geode Capital Management LLC0.79%11,184$41.94kInstitution
Blackrock Inc0.72%10,132$38.00kInstitution
Wells Fargo Company0.71%10,024$37.59kInstitution
Tower Research Capital LLC Trc0.16%2,301$8.63kInstitution
Ubs Group Ag0.07%1,023$3.84kInstitution

1 of 3

GTBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GTBP49.22%50.78%Net Buying
TCBP0.03%7.33%
LIXT2.45%97.55%Net Buying
AZTR5.35%55.13%Net BuyingNet Buying
NLSP22.87%0.00%
View Top Biotech Stocks

Gt Biopharma Stock Ownership FAQ

Who owns Gt Biopharma?

Gt Biopharma (NASDAQ: GTBP) is owned by 82.53% institutional shareholders, 85.15% Gt Biopharma insiders, and 0.00% retail investors. Michael Martin Breen is the largest individual Gt Biopharma shareholder, owning 856,218.00 shares representing 60.44% of the company. Michael Martin Breen's Gt Biopharma shares are currently valued at $3.21M.

If you're new to stock investing, here's how to buy Gt Biopharma stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.